Principal Investigator and Provider of Healthcare Sample Clauses

Principal Investigator and Provider of Healthcare. Hlavní zkoušející a Poskytovatel zdravotních služeb 2.1 In the event that employment or any other relationship between Principal Investigator and Provider of Healthcare is terminated or Principal Investigator is unable or unwilling to act as Principal Investigator for other reason, Principal Investigator shall provide immediate written notice of such event to Sponsor. In such a case Sponsor has rights take the necessary action to continue the Study, or terminate the Study if no other solution has been found. 2.1 Dojde-li k ukončení pracovněprávního nebo jiného vztahu mezi Hlavním zkoušejícím a Poskytovatelem zdravotních služeb, nebo Hlavní zkoušející není z jiných důvodů schopen či ochoten vykonávat funkci hlavního zkoušejícího, je Hlavní zkoušející povinen neprodleně písemně informovat Zadavatele o této skutečnosti. V takovém případě je Zadavatel oprávněn přijmout nezbytná opatření pro zajištění pokračování Studie nebo v případě nezbytnosti Studii ukončit.
AutoNDA by SimpleDocs
Principal Investigator and Provider of Healthcare. Hlavní zkoušející a Poskytovatel zdravotních služeb 2.1 In the event that employment or any other relationship between Principal Investigator and Provider of Healthcare is terminated, Principal Investigator shall provide immediate written notice of such event to Sponsor. In such a case Sponsor has rights take the necessary action to continue the Study, or terminate the Study if no other solution has been found. 2.1 Dojde-li k ukončení pracovněprávního nebo jiného vztahu mezi Hlavním zkoušejícím a Poskytovatelem zdravotních služeb, je Hlavní zkoušející povinen neprodleně písemně informovat Zadavatele o této skutečnosti. V takovém případě je Zadavatel oprávněn přijmout nezbytná opatření pro zajištění pokračování Studie nebo v případě nezbytnosti Studii ukončit.
Principal Investigator and Provider of Healthcare agree that all research data and results generated during the course of the Study shall be the property of Sponsor. Principal Investigator and Provider of Healthcare further agree to execute any documents or undertake any further actions if requested by Sponsor to evidence transfer of title to such data and results. a) Hlavní zkoušející a Poskytovatel zdravotních služeb xxxxxxxxx, xx xxxxxxx xxxxxxxx xxxxx a výsledky získané v průběhu Studie jsou vlastnictvím Zadavatele. Hlavní zkoušející a Poskytovatel zdravotních služeb dále potvrzují, že na žádost Zadavatele vyhotoví veškeré dokumenty a uskuteční veškerá právní jednání za účelem doložení převodu vlastnického práva k takovým údajům a výsledkům.
Principal Investigator and Provider of Healthcare agree that all research data and results generated during the course of the Study shall be the property of Sponsor. Principal Investigator and Provider of Healthcare further agree to execute any documents or undertake any further actions if requested by Sponsor to evidence transfer of title to such data and results. a) Hlavní zkoušející a Poskytovatel zdravotních služeb potvrzují, že veškeré výzkumné údaje a výsledky získané v průběhu Studie jsou vlastnictvím Zadavatele. Hlavní zkoušející a Poskytovatel zdravotních služeb dále potvrzují, že na žádost Zadavatele vyhotoví veškeré dokumenty a uskuteční veškerá právní jednání za účelem doložení převodu vlastnického práva k takovým údajům a výsledkům. b) Subject to the terms and conditions of this Agreement, Provider of Healthcare and Principal Investigator have the right to publish or publicly present the results of the Study. Principal Investigator and Provider of Healthcare agree not to publish or publicly present any interim results of the Study. Principal Investigator and Provider of Healthcare further agree to provide forty-five (45) days written notice to Sponsor prior to submission for publication or presentation to permit Sponsor to review drafts of abstracts and manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, e.g. any computer access system such as the Internet, World Wide Web etc. (hereinafter collectively or individually called a “Public Presentation”) which report any results arising out of the Study. Sponsor shall have the right to review and comment on any Public Presentation.
Principal Investigator and Provider of Healthcare agree that all research data and results generated during the course of the Study shall be the property of Sponsor. Principal Investigator and Provider of Healthcare further agree to execute any documents or undertake any further actions if requested by Sponsor to evidence transfer of title to such data and results. a) Hlavní zkoušející a Poskytovatel zdravotních služeb potvrzují, že veškeré výzkumné údaje a výsledky získané v průběhu Studie jsou vlastnictvím Zadavatele. Hlavní zkoušející a Poskytovatel zdravotních služeb dále potvrzují, že na žádost Zadavatele vyhotoví veškeré dokumenty a uskuteční veškerá právní jednání za účelem doložení převodu vlastnického práva k takovým údajům a výsledkům.
Principal Investigator and Provider of Healthcare. Hlavní zkoušející a Poskytovatel zdravotních služeb 2.1 In the event that employment or any other relationship between Principal Investigator and Provider of Healthcare is terminated, Principal Investigator shall provide immediate written notice of such event to Sponsor. In such a case Sponsor has rights take the necessary action to 2.1 Dojde-li k ukončení pracovněprávního nebo jiného vztahu mezi Hlavním zkoušejícím a Poskytovatelem zdravotních služeb, je Hlavní zkoušející povinen neprodleně písemně informovat Zadavatele o této skutečnosti. V takovém případě je Zadavatel oprávněn přijmout nezbytná opatření pro zajištění continue the Study or terminate the Study if no other solution has been found. pokračování Studie nebo v případě nezbytnosti Studii ukončit.
Principal Investigator and Provider of Healthcare agree that all research data and results generated during the course of the Study shall be the property of Sponsor. Principal Investigator and Provider of Healthcare further agree to execute any documents or undertake any further actions if requested by Sponsor to evidence transfer of title to such data and results.
AutoNDA by SimpleDocs

Related to Principal Investigator and Provider of Healthcare

  • Principal Investigator The Research will be supervised by __________________ ("Principal Investigator"). If for any reason the individual is unable to continue to serve as Principal Investigator and a successor acceptable to both the University and the Sponsor is not available, this agreement shall be terminated as provided in Article 9. The Principal Investigator may work with others at the University (“Associates”) in conducting the Research.

  • Clinical Management for Behavioral Health Services (CMBHS) System 1. request access to CMBHS via the CMBHS Helpline at (000) 000-0000. 2. use the CMBHS time frames specified by System Agency. 3. use System Agency-specified functionality of the CMBHS in its entirety. 4. submit all bills and reports to System Agency through the CMBHS, unless otherwise instructed.

  • SAFETY & HEALTH A. Employees covered by this Agreement who are uniformly and periodically required by the Company to take physical examinations because of the duties they perform shall be scheduled and paid for the time spent taking such examinations in accordance with the Company's established procedures for employees under this Agreement. The Company will schedule the exam in a way that is not unduly burdensome to the employee or the Company. The provisions of this Paragraph shall not apply to employees required to take physical examinations after absence due to illness or any physical examinations other than those specified above. B. The Company hereby agrees to maintain safe, sanitary and healthful working conditions in all shops and facilities and to maintain on all shifts emergency first aid equipment at a first aid station to take care of its employees in case of accident or illness, and that sufficient employees will be given initial and recurrent first aid / CPR training. It is understood that this does not require the Company to maintain a nurse or doctor on the property, but in an emergency the Company will utilize the appropriate emergency services. C. The Company agrees to furnish good drinking water and sanitary fountains; the floors of the toilets and washrooms will be kept in good repair and in a clean, dry, sanitary condition. Employees will cooperate in maintaining the foregoing conditions Shops and washrooms will be lighted and heated in the best manner possible consistent with the source of heat and light available. Individual lockers will be provided for all employees where space and lockers are available. Every effort will be made as early as possible to provide space and lockers for all employees. D. The Company, Union, and employees will cooperate toward the prevention of accidents and the furtherance of an aggressive safety program. A joint Company- E. The Company shall furnish all necessary safety devices for employees working on hazardous or unsanitary work, and employees will be required to use or wear such devices in performing such work. F. The Company will furnish appropriate aprons, gloves and shoes to all employees required to work with acids and chemicals that are injurious to clothing while such employees are engaged in such activities, and employees will be required to wear such equipment. G. Employees taken sick or injured while at work, shall be given medical attention as promptly as reasonably practicable. Employees will not be refused permission to return to work because they have not signed releases of liability pending the disposition or settlement of any claims which they may have for compensation arising out of such sickness or injury. H. In cases of occupational injury or illness employees may elect to be treated by their personal physician, and decline treatment from others, provided they have their physician registered with United's medical department prior to the occurrence of illness or injury. The Company's physician will retain the right to monitor the employee's course of treatment. I. United will maintain a Bloodborne Pathogen Exposure Control Plan which satisfies the requirements of the OSHA Bloodborne Pathogen regulations. Corporate Safety agrees to consider any proposed changes to the Plan that may be suggested by the Union in an effort to improve the safety of employees in their work environment and to solicit comments from the Union whenever routine revisions are made to the Plan. The Company agrees to make available, at no cost to covered employees, complete post- exposure evaluation including necessary blood work and medications. J. The Flight Safety Committee shall function as described in Letter of Agreement #21. K. In the event the IBT and the Company jointly petition the National Transportation Safety Board (NTSB) for, and are granted, formal party or observer status in connection with an investigation involving a Company incident or accident, the Company and the IBT will L. Any MSAP program will be covered in a stand alone MOU between the Company, the Union and the FAA. While there is a valid MOU the Company will sponsor 1 full-time, IBT representative to participate on the ERC scheduled Mon-Fri, on traditional business hours. This position will in all respects be treated in a similar manner regarding necessary transportation as other IBT staff positions. The Company agrees to supply access to office space appropriate for the confidentiality needs of the position and access to office supplies. M. In the event the Company requires employees covered by this Agreement to wear protective footwear as personal protective equipment, the Company will provide an allowance to such employees for the actual cost of protective footwear that complies with Company standards. Such allowance shall be up to a maximum of $52.80 per year per employee on a rolling calendar basis.

  • Investigator Where a difference arises between the parties relating to the dismissal, discipline or suspension of an employee, or to the interpretation, application, operation or alleged violation of this agreement, including any questions as to whether a matter is arbitrable, during the term of the collective agreement, an arbitrator agreed to by the parties shall, at the request of either party: (a) investigate the difference; (b) define the issue in the difference; and (c) make written recommendations to resolve the difference within five days of the date of receipt of the request and for those five days from that date time does not run in respect of the grievance procedure. The parties agree that this procedure will not be invoked until the grievance procedure has been completed.

  • Medical Procedures 21.01 The Board shall distribute a copy of its Operating Procedures for administration of prescribed medication to pupils in schools and Procedures for health support services to each Teacher. 21.02 In accordance with Operating Procedure Special Education Services 8, a Teacher may refuse without prejudice a request to administer medications except in life-threatening situations.

  • Contractor Key Personnel ‌ The Contractor shall assign a Corporate OASIS SB Program Manager (COPM) and Corporate OASIS SB Contract Manager (COCM) as Contractor Key Personnel to represent the Contractor as primary points-of-contact to resolve issues, perform administrative duties, and other functions that may arise relating to OASIS SB and task orders solicited and awarded under OASIS SB. Additional Key Personnel requirements may be designated by the OCO at the task order level. There is no minimum qualification requirements established for Contractor Key Personnel. Additionally, Contractor Key Personnel do not have to be full-time positions; however, the Contractor Key Personnel are expected to be fully proficient in the performance of their duties. The Contractor shall ensure that the OASIS SB CO has current point-of-contact information for both the COPM and COCM. In the event of a change to Contractor Key Personnel, the Contractor shall notify the OASIS SB CO and provide all Point of Contact information for the new Key Personnel within 5 calendar days of the change. All costs associated with Contractor Key Personnel duties shall be handled in accordance with the Contractor’s standard accounting practices; however, no costs for Contractor Key Personnel may be billed to the OASIS Program Office. Failure of Contractor Key Personnel to effectively and efficiently perform their duties will be construed as conduct detrimental to contract performance and may result in activation of Dormant Status and/or Off-Ramping (See Sections H.16. and H.17.).

  • Pharmacovigilance Licensee shall maintain until the termination of this Agreement (or, as applicable, until the rights and obligations intended to survive termination of this Agreement have been fulfilled) pharmacovigilance and risk management systems, procedures and documentation needed to perform and comply with its regulatory obligations and its related obligations under this Agreement. Licensee shall ensure that it will comply with all Applicable Law regarding Licensed Product in the Territory, including, without limitation, those laws and regulations relating to risk management, drug safety and pharmacovigilance. If Licensee becomes aware of any adverse reaction relating to Licenced Product in connection with this Agreement, Licensee shall inform MPP and Pfizer within twenty-four (24) hours of its becoming aware and cooperate with Pfizer in fulfilling Pfizer’s reporting responsibilities under Applicable Law. Licensee will be responsible for fulfilling all pharmacovigilance activities pursuant to the local regulations and requirements for the Licenced Products in the Territory and provide MPP and Pfizer with a report containing information regarding all such activities. Such report shall be provided annually, on February 1 of each year, and otherwise on reasonable request by MPP or Pfizer to both MPP and Pfizer’s pharmacovigilance contact as may be designated by Pfizer from time to time. Licensee shall notify MPP and Pfizer forthwith of the receipt of an enquiry from an Agency in the Territory relating to Licensed Product that concerns any safety issue. If Licensee becomes aware of any action that may be, will be or has been taken by an Agency for a safety reason connected with Licensed Product, it shall immediately, and in any event no later than twenty-four

  • HEALTH PROGRAM 3701 Health examinations required by the Employer shall be provided by the Employer and shall be at the expense of the Employer. 3702 Time off without loss of regular pay shall be allowed at a time determined by the Employer for such medical examinations and laboratory tests, provided that these are performed on the Employer’s premises, or at a facility designated by the Employer. 3703 With the approval of the Employer, a nurse may choose to be examined by a physician of her/his own choice, at her/his own expense, as long as the Employer receives a statement as to the fitness of the nurse from the physician. 3704 Time off for medical and dental examinations and/or treatments may be granted and such time off, including necessary travel time, shall be chargeable against accumulated income protection benefits.

  • Behavioral Health Services Behavioral health services include the evaluation, management, and treatment for a mental health or substance use disorder condition. For the purpose of this plan, substance use disorder does not include addiction to or abuse of tobacco and/or caffeine. Mental health or substance use disorders are those that are listed in the most updated volume of either: • the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association; or • the International Classification of Disease Manual (ICD) published by the World Health Organization. This plan provides parity in benefits for behavioral healthcare services. Please see Section 10 for additional information regarding behavioral healthcare parity. This plan covers behavioral health services if you are inpatient at a general or specialty hospital. See Inpatient Services in Section 3 for additional information. This plan covers services at behavioral health residential treatment facilities, which provide: • clinical treatment; • medication evaluation management; and • 24-hour on site availability of health professional staff, as required by licensing regulations. This plan covers intermediate care services, which are facility-based programs that are: • more intensive than traditional outpatient services; • less intensive than 24-hour inpatient hospital or residential treatment facility services; and • used as a step down from a higher level of care; or • used a step-up from standard care level of care. Intermediate care services include the following: • Partial Hospital Program (PHP) – PHPs are structured and medically supervised day, evening, or nighttime treatment programs providing individualized treatment plans. A PHP typically runs for five hours a day, five days per week. • Intensive Outpatient Program (IOP) – An IOP provides substantial clinical support for patients who are either in transition from a higher level of care or at risk for admission to a higher level of care. An IOP typically runs for three hours per day, three days per week.

  • Medical Verification The Town may require medical verification of an employee’s absence if the Town perceives the employee is abusing sick leave or has used an excessive amount of sick leave. The Town may require medical verification of an employee’s absence to verify that the employee is able to return to work with or without restrictions.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!